Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash Flows From Operating Activities:
Consolidated net income	$ 402,061	$ 384,818	$ 329,677
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Loss on sale of real estate and impairment, net	(919)	2,466	3,581
Early debt retirement	0	5,833	68
Depreciation and amortization	213,743	209,398	209,101
Amortization of loan costs	5,140	5,228	4,921
Debt premium amortization	0	0	(62)
Equity in (income)/loss of unconsolidated joint ventures	(6,520)	(6,248)	(2,713)
Distributions of income from unconsolidated joint ventures	395	1,331	1,328
Proceeds from insurance claims, net	(4,016)	(26,753)	37,561
Compensation expense related to incentive plans	7,252	9,372	17,833
Revenue recognized from membership upgrade sales upfront payments	(13,736)	(16,433)	(14,719)
Commission expense related to memberships sales	4,969	4,577	4,211
Deferred income tax benefit	(1,222)	(354)	(10,488)
Changes in assets and liabilities:
Manufactured homes, net	(44,701)	12,463	(31,825)
Notes receivable, net	13,245	(4,591)	(4,646)
Deferred commission expense	(6,602)	(7,452)	(7,411)
Other assets, net	5,783	(4,291)	(1,362)
Accounts payable and other liabilities	(7,704)	212	(25,778)
Deferred membership revenue	5,934	31,148	35,313
Rents and other customer payments received in advance and security deposits	(1,954)	(4,003)	3,415
Net cash provided by operating activities	571,148	596,721	548,005
Cash Flows From Investing Activities:
Real estate acquisitions, net	0	(1,334)	(9,326)
Proceeds from sale properties	2,525	0	0
Investment in unconsolidated joint ventures	(9,689)	(10,343)	(9,275)
Distributions of capital from unconsolidated joint ventures	13,924	15,415	5,625
Proceeds from insurance claims, net	9,358	19,703	5,309
Issuance of notes receivable	(56,110)	0	0
Capital improvements	(237,091)	(241,279)	(317,086)
Net cash used in investing activities	(277,083)	(217,838)	(324,753)
Cash Flows From Financing Activities:
Proceeds from stock options and employee stock purchase plan	1,506	1,790	1,984
Gross proceeds from the issuance of common stock	0	317,388	0
Distributions:
Common Stockholders	(387,963)	(350,598)	(326,404)
Common OP Unitholders	(17,026)	(17,117)	(16,156)
Preferred Stockholders	(16)	(16)	(16)
Share based award tax withholding payments	(2,258)	(1,908)	(1,932)
Principal payments and mortgage debt repayment	(151,822)	(64,460)	(164,583)
Mortgage notes payable financing proceeds	0	0	463,753
Term loan proceeds	240,000	0	0
Term loan repayment	0	(300,000)	0
Line of credit repayment	(867,000)	(543,500)	(688,000)
Line of credit proceeds	895,000	589,500	521,000
Debt issuance and defeasance costs	(2,494)	(11,268)	(5,033)
Other	(436)	(4,055)	(275)
Net cash used in financing activities	(292,509)	(384,244)	(215,662)
Net increase (decrease) in cash and restricted cash	1,556	(5,361)	7,590
Cash and restricted cash, beginning of period	24,576	29,937	22,347
Cash and restricted cash, end of period	26,132	24,576	29,937
Supplemental information:
Cash paid for interest, net	129,968	139,975	130,234
Cash paid for the purchase of manufactured homes	77,500	43,467	106,627
Real estate acquisitions:
Investment in real estate	0	(1,334)	(10,057)
Other assets, net	0	0	13
Rents and other customer payments received in advance and security deposits	0	0	718
Real estate acquisitions, net	$ 0	$ (1,334)	$ (9,326)